|Bid||208.25 x 800|
|Ask||208.35 x 900|
|Day's Range||206.84 - 209.07|
|52 Week Range||141.41 - 210.10|
|Beta (5Y Monthly)||0.63|
|PE Ratio (TTM)||56.20|
|Earnings Date||Nov 03, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||1.00 (0.49%)|
|Ex-Dividend Date||Jul 20, 2021|
|1y Target Est||225.00|
PARSIPPANY, N.J., October 18, 2021--Robert J. Polzer, PhD, will succeed current EVP and President of R&D at Zoetis, Dr. Catherine Knupp, DVM, MS.
PARSIPPANY, N.J., October 14, 2021--The Board of Directors of Zoetis Inc. has declared a fourth quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share.
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.